Targeted chemotherapy of visceral leishmaniasis by lactoferrin-appended amphotericin B-loaded nanoreservoir: in vitro and in vivo studies.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Exploitation of lactoferrin-appended amphotericin B bearing nanoreservoir (LcfPGNP-AmB) for targeted eradication of Leishmania donovani.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Nanomedicine (Lond)

Title: Nanomedicine (London, England)

Publisher: Future Medicine Ltd

ISSN (Electronic): 1748-6963

ISSN (Print): 1743-5889

Publication date (Electronic): 2015

Volume: 10

Issue: 7

Affiliations

[1 ] Pharmaceutics Division, CSIR-Central Drug Research Institute, B 10/1, Sector 10, Jankipuram Extension, Lucknow-226031, India.

Article

DOI: 10.2217/nnm.14.182

PubMed ID: 25929567

SO-VID: f678baf7-6eb8-49d6-b3cc-08fe1a5846f9

History

Keywords: anti-leishmanial activity,antigen-presenting cells,cytokines,macrophages,targeted drug delivery

Data availability:

Keywords: anti-leishmanial activity, antigen-presenting cells, cytokines, macrophages, targeted drug delivery

Targeted chemotherapy of visceral leishmaniasis by lactoferrin-appended amphotericin B-loaded nanoreservoir: in vitro and in vivo studies.

Read this article at

Abstract

Related collections

Herbal Medicines Journal (Herb Med J)

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 12